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Abstract
Background: Epithelial-mesenchymal transition of tubular epithelial cells, which is characterized by a loss of epithelial cell
characteristics and a gain of ECM-producing myofibroblast characteristics, is an essential mechanism that is involved in
tubulointerstitial fibrosis, an important component of the renal injury that is associated with diabetic nephropathy. Under
diabetic conditions, p38 MAPK activation has been reported in glomeruli and mesangial cells; however, studies on p38
MAPK in TECs are lacking. In this study, the role of p38 MAPK in AP-1 activation and in the EMT in the human proximal
tubular epithelial cell line (HK-2) under high glucose concentration conditions is investigated.
Methodology/Principal Findings: A vector for small interfering RNA that targets p38 MAPK was constructed; the cells were
then either transfected with p38 siRNA or pretreated with a chemical inhibitor of AP-1 and incubated with low glucose plus
TGF-b1 or high glucose for 48 h. Cells that were not transfected or pretreated and were exposed to low glucose with or
without TGF-b1 or high glucose for 48 h were considered to be the controls. We found that high glucose induced an
increase in TGF-b1. And high glucose-induced p38 MAPK activation was inhibited by p38 siRNA (P,0.05). A significant
decline in E-cadherin and CK expression and a notable increase in vimentin and a-SMA were detected when exposed to low
glucose with TGF-b1 or high glucose, and a significant raise of secreted fibronectin were detected when exposed to high
glucose; whereas these changes were reversed when the cells were treated with p38 siRNA or AP-1 inhibitor (P,0.05). AP-1
activity levels and Snail expression were up-regulated under high glucose conditions but were markedly down-regulated
through knockdown of p38 MAPK with p38 siRNA or pretreatment with AP-1 inhibitor (P,0.05).
Conclusion: This study suggests that p38 MAPK may play an important role in the high glucose-induced EMT by activating
AP-1 in tubular epithelial cells.
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Introduction
Glomerular mesangial expansion and podocyte loss are
important early features of diabetic nephropathy, and tubuloin-
terstitial injury and fibrosis are critical for the progression of
diabetic nephropathy to kidney failure. It has been shown that
tubulointerstitial fibrosis (TIF) is a more consistent predictor of
functional impairment than glomerular damage. Accumulating
evidence suggests that TECs play a pivotal role in TIF by
undergoing EMT, which increases extracellular matrix (ECM)
synthesis [1–3]. The EMT of tubular epithelial cells is proposed as
an orchestrated, highly-regulated process that consists of four key
steps [4]: (1) loss of epithelial cell adhesion; (2) de novo a-SMA
expression and actin reorganization; (3) disruption of the tubular
basement membrane; and (4) enhanced cell migration and
invasion.
The transforming growth factor-b (TGF-b) family of secreted
factors regulates various biological processes, including cell
proliferation, differentiation and apoptosis [5]. TGF-b can induce
mesenchymal transdifferentiation in epithelial and endothelial cells
through various signal pathways[6]. Thus in our study, to further
confirm whether high glucose could induce EMT in TECs, we
observed expression of TGF-b1 under high glucose conditions,
given the fact that TGF-b is the key inducer of EMT [7,8].
p38 MAPK is a member of the MAPK family and is essential
for the regulation of many cellular processes, including inflam-
mation, cell differentiation, cell growth and cell death [9–11]. p38
MAPK mediates the signals that are relevant to thedevelopment of
diabetic nephropathy. It is thought that p38 MAPK is a signal
transducer in the underlying diabetic nephropathy pathways, and
it has been proposed that the agents that inhibit the p38 MAPK
signaling pathway may reduce the formation of the ECM in the
glomerular mesangium and block the thickening of the glomerular
basement membrane, thus preventing the development of diabetic
nephropathy [12]. There is a wealth of data that supports the
central role of the p38 MAPK signaling pathway in high glucose-
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that high levels of glucose can activate the p38 MAPK signaling
pathway in renal cells and induce the phosphorylation of p38
MAPK, which promotes the production of fibronectin by the
mesangial cells [18–21]. In addition, there is enough evidence that
TGF-b signals through MAPKs [22], and the activation of p38
MAPK is required in TGF-b-induced EMT in mammary epithelial
cells [23]. Therefore, we decided to examine whether the p38
MAPK signaling pathway contributes to the EMT that is induced
by high glucose in human proximal tubular epithelial cells.
AP-1, which is a transcription factor, is a heterodimeric protein
that is composed of proteins of the c-Fos, c-Jun, ATF and JDP
families. AP-1 regulates gene expression in response to a variety of
stimuli, including cytokines, growth factors, stress, and bacterial
and viral infections [24–28]. It has been shown that a tubular
overactivation of AP-1 and a simultaneous up-regulation of certain
proinflammatory and profibrogenic genes are markers of progres-
sive renal disease in humans [29]. The activation of AP-1 through
dimerization that is mediated by leucine zippers is known to be
promoted by a variety of upstream protein kinases [30]. Upstream
signaling pathways, which include mitogen-activated protein
kinases (MAPKs), regulate the transcriptional activity and the
half-life of certain proteins and produce AP-1 dimers of different
transcriptional specificity [31]. Because MAPKs have been shown
to be involved in a crucial step in the up-regulation of AP-1
activation in various types of cultured cells via multiple
mechanisms, we attempted to examine the possible involvement
of p38 MAPK, the major upstream kinase, in AP-1 activation in
HK2 cells.
The purpose of this study was to determine the role of p38
MAPK in high glucose-induced AP-1 activation and in the EMT
in the HK-2 cells. A vector for small interfering RNA that targets
p38 MAPK was constructed; the cells were then either transfected
with p38 siRNA or pretreated with a chemical inhibitor of AP-1
and incubated with low glucose (5.5 mM glucose) plus TGF-b1o r
high glucose (30 mM glucose) for 48 h. Cells that were not
transfected or pretreated and were exposed to low glucose
(5.5 mM glucose) with or without TGF-b1 or high glucose
(30 mM glucose) for 48 h were considered to be the controls. In
this study, it was found that the activation of p38 MAPK under
high glucose conditions led to EMT in HK-2 cells. In addition,
p38 siRNA partially suppressed a-SMA and vimentin expression
and inhibited fibronectin synthesis. The activation of AP-1 in the
high glucose-induced EMT and its partial abrogation by p38
siRNA were also shown. Furthermore, p38/AP-1 promoted the
EMT via suppression of E-cadherin through up-regulated Snail
expression.
Results
SiRNA silenced p38 MAPK in HK-2 cells cultured with
high glucose
To confirm whether high glucose could induce the epithelial-
mesenchymal transition in the HK-2 cells, the cells were treated
with low glucose (5.5 mM glucose) plus TGF-b1 or high glucose
(30 mM glucose). We found that an increase in TGF-b1 of the
HK-2 cells was induced by high glucose (Figure 1). The cells that
were cultured in 5.5 mM glucose showed a typical epithelial
cuboidal shape with the characteristic cobblestone morphology
and abundant microvilli and mitochondria; however, the cells that
were exposed to high glucose displayed distinct morphological
changes (Figure 2 and 3). The expression of the epithelial
phenotypic markers, E-cadherin and cytokeratin, as well as the
mesenchymal phenotypic markers, a-SMA and vimentin, were
determined (Figures 4 and 5). Under low glucose conditions, p38
MAPK gene silencing significantly inhibited the expression and
phosphorylation of p38 MAPK (P,0.05) (Figure 6). To investigate
the role of p38 MAPK in the high glucose-induced EMT, p38
MAPK and phosphorylated p38 were determined. The expres-
sions of p38 MAPK under high glucose conditions were of no
significant difference compared with that cultured in low glucose.
But high glucose increased the phosphorylation of p38 MAPK in
HK-2 cells. Knockdown of p38 gene lead to decrease of both
expression and phosphorylation of p38 MAPK, the latter of which
was induced by high glucose (P,0.05) (Figure 7).
The role of p38 MAPK in the expression of E-cadherin,
cytokeratin, vimentin, and a-SMA under high glucose
conditions
E-cadherin is a Ca
2+-dependent cell adhesion molecule that
plays a significant role in the maintenance of renal epithelial
polarity. Cytokeratins are proteins of keratin-containing interme-
diate filaments that are found in the intracytoplasmic cytoskeleton
of the cells of epithelial tissue. Loss of E-cadherin and CK
expression is considered to be the early changes in TGF-b-induced
EMT [32]. High glucose or low glucose with TGF-b1 decreased
the expression of E-cadherin and CK, but the expression of those
proteins increased after pre-treatment with p38 siRNA (Figures 4,
5, 8). In addition, CK mRNA was down-regulated under high
glucose conditions but was significantly up-regulated after pre-
treatment with p38 siRNA (P,0.05) (Figure 5).
a-SMA and vimentin are cytoskeletal proteins found in
fibroblasts but not in TECs. In cells cultured with 5.5 mM
glucose, a-SMA and vimentin were not detected. However, high
glucose or low glucose plus TGF-b1 resulted in a significant
increase in a-SMA and vimentin expression, which was blocked by
pre-treatment with p38 siRNA (P,0.05) (Figures 4, 5, 8). It was
further confirmed that the vimentin mRNA levels were signifi-
cantly increased when the cells were treated with high glucose, but
these levels were reduced after pre-treatment with p38 siRNA
(P,0.05) (Figure 5).
Figure 1. The expression of TGF-b1 in HK-2 cells by Western
blot. TGF-b1 was measured by Western blot of the HK-2 cells cultured
in 5.5 mM glucose (lane 1), 30 mM glucose for 24 h (lane 2), 30 mM
glucose for 48 h (lane 3).
aP,0.05 vs. 5.5 mM glucose.
doi:10.1371/journal.pone.0022806.g001
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Fibronectin is a high-molecular-weight extracellular matrix
glycoprotein that binds to membrane-spanning receptor proteins
and therefore plays a major role in cell adhesion, growth,
migration and differentiation. Fibronectin is also central to the
processes of wound healing and embryonic development. We
Figure 2. Inverted microscope analysis of the HK-2 cells cultured under different conditions. (A) A typical epithelial cuboidal shape of the
HK-2 cells cultured in 5.5 mM glucose condition were shown, with the characteristic cobblestone morphology. (B–C)Morphological changes of the
HK-2 cells. The cells became more elongated, less adhered and lost their apical-to-basal polarity after treated with 30 mM glucose(B) or 30 mM
glucose+Cont siRNA(C).(D–F)Changes of the cells were reversed, which were exposed to 30 mM glucose+p38 siRNA for 24 h(D) or for 48 h(E) or
30 mM glucose+AP-1 inhibitor(F).
doi:10.1371/journal.pone.0022806.g002
Figure 3. Transmission electron microscopic analysis of the HK-2 cells cultured under different conditions. (A–C)The HK-2 cells under
30 mM glucose (B) or 30 mM glucose+Cont siRNA (C) showed decreased number of microvilli, mitochondria and increased volume density of rough
endoplasmic reticulum compared to that of the cells cultured in 5.5 mM glucose(A). (D–F)Changes of the cells were reversed,which were cultured in
the 30 mM glucose+p38 siRNA for 24 h(D) or 48 h(E) or 30 mM glucose+AP-1 inhibitor(F).
doi:10.1371/journal.pone.0022806.g003
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high glucose for 48 hours. Secretion of fibronectin was signifi-
cantly up-regulated by the stimulation of high glucose (P,0.05),
whereas the level of secretions was markedly decreased after pre-
treatment with p38 siRNA (P,0.05) (Figure 9).
The activation of AP-1 in high-glucose-treated HK-2 cells
Because MAPKs have been shown to play a critical role in the
up-regulation of AP-1 activity in various types of cultured cells via
multiple mechanisms, we attempted to examine the possible
involvement of p38 MAPK, which is the major upstream kinase, in
AP-1 activation in HK-2 cells. The levels of AP-1 binding activity
increased after treatment with high glucose but decreased after
transfection with p38 siRNA (P,0.05) (Figure 10). To further
study the transactivation of AP-1 in high-glucose-treated HK-2
cells, experiments using [6]-Gingerol [33], which is a chemical
inhibitor of AP-1, demonstrated that it could partially inhibit high-
glucose-induced activation of AP-1, but was irrelevant to the
regulation of p38 expression and phosphorylation. (P,0.05)
(Figure 10 and 11).
The effect of AP-1 on E-cadherin, cytokeratin, vimentin,
and a-SMA expression under high glucose conditions
To determine the role of AP-1 in the EMT, E-cadherin, CK,
vimentin, and a-SMA expression was assessed. Compared to cells
that were incubated with 5.5 mM glucose, the expression of E-
cadherin and CK was significantly decreased under high glucose
conditions or low glucose with TGF-b1 but was increased after
pre-treatment with the AP-1 inhibitor, protein expression was
increased (P,0.05) (Figure 4, 8, 12). It was further confirmed that
the CK mRNA levels were markedly diminished under high
glucose conditions; however, the levels were notably increased by
pre-treatment with the AP-1 inhibitor (P,0.05) (Figure 12).
a-SMA and vimentin were not detected in cells that were
incubated with 5.5 mM glucose. After culture with high glucose or
low glucose with TGF-b1, the expression of a-SMA and vimentin
were markedly increased but decreased with pre-treatment with
the AP-1 inhibitor (P,0.05) (Figure 4, 8, 12). The levels of
vimentin mRNA were increased when the cells were treated with
high glucose, whereas they were significantly decreased after pre-
treatment with the AP-1 inhibitor (P,0.05) (Figure 12).
The effect of AP-1 on fibronectin synthesis in HK-2 cells
In the culture media from the cells treated with high glucose, the
concentration of fibronectin was significantly greater than that of
the media from the cells treated with 5.5 mM glucose; the
concentration of fibronectin after pre-treatment with the AP-1
inhibitor was significantly decreased compared to the concentra-
tion after treatment with high glucose (Figure 9).
The role of p38 MAPK/AP-1 in Snail expression under
high glucose conditions
Snail is a member of the Snail family of zinc finger transcription
factors that induce the EMT initially identified as a gene
controlling cell migration in the neural crest and developing
mesoderm in the chick embryo [34]. Snail mRNA represses
CDH1/E-cadherin and other epithelial genes, and induces the
expression of mesenchymal genes in epithelial cells of diverse
origin [35–37]. Therefore, we observed the effect of p38 MAPK
and AP-1 on Snail mRNA expression in high glucose-induced
EMT. In our study, Snail mRNA expression was amplified by the
stimulation of high glucose compared to 5.5 mM glucose
(P,0.05), whereas Snail mRNA expression was significantly
decreased after pre-treatment with p38 siRNA or the AP-1
inhibitor (P,0.05) (Figure 13).
Figure 4. Expression of E-cadherin, CK, a-SMA, vimentin in HK-2 cells by immunochemistry. (A–C)The HK-2 cells under 30 mM glucose(B)
or 30 mM glucose+cont siRNA(C) showed a loss of CK and E-cadherin and an increase of a-SMA and vimentin expression compared to that of the cells
under 5.5 mM glucose condition(A).(D–F)These changes were prevented by exposed to 30 mM glucose+p38siRNA for 24 h(D) or 48 h(E) or+AP-1
inhibitor(F).
doi:10.1371/journal.pone.0022806.g004
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22806Figure 5. Expression of E-cadherin, CK, a-SMA, vimentin in HK-2 cells by Western blot and RT-PCR analysis. (A–B)E-cadherin
expression(A1,A2) and a-SMA(B1,B2) were analyzed by Western blot of the HK-2 cells cultured in 5.5 mM glucose (lane 1), 30 mM glucose (lane 2),
30 mM glucose+Cont siRNA(lane 3), 30 mM glucose+p38 siRNA for 24 h(lane 4), 30 mM glucose+p38 siRNA for 48 h(lane 5).(C–D)mRNA of CK (C1,C2)
and vimentin(D1,D2) were analyzed by RT-PCR of the HK-2 cells cultured in 5.5 mM glucose (lane 1), 30 mM glucose (lane 2), 30 mM glucose+Cont
siRNA(lane 3), 30 mM glucose+p38 siRNA for 24 h(lane 4), 30 mM glucose+p38 siRNA for 48 h(lane 5).Values represent the mean 6 SD,
aP,0.05 vs.
5.5 mM glucose,
bP,0.05 vs. 30 mM glucose.
doi:10.1371/journal.pone.0022806.g005
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TIF has been recognized as a common terminal pathway for
almost all forms of chronic kidney disease. TECs are pivotal in the
processes of TIF through EMT because TECs are considered to
be an essential source of myofibroblasts, which promote ECM
synthesis [38,39]. Increasing evidence indicates that TECs, which
are the major constituents of the renal parenchyma, are not
innocent bystanders but play a decisive role in the evolution of
renal fibrosis. Recent clinical studies have also demonstrated the
existence of EMT in human renal biopsies [40].
p38 MAPK activation is a key modulator in the progression of
renal diseases and is thought to occur in various kinds of cells,
including mesangial cells [41] and vascular endothelial cells [42];
however, little is known about the activation of p38 MAPK in
renal tubular epithelial cells. Currently, there is a wealth of data
that supports the central role of the p38 MAPK signaling pathway
in high glucose-induced cell damage [43–46]. Therefore, We
focused on the p38 MAPK signaling pathway to determine
whether it mediates high glucose-induced EMT. Becasuse the
activation of TGF-b signaling is sufficient to induce EMT in
cultured epithelial cells and MAPK signaling pathways have been
implicated inTGF-b-induced EMT [47], expression of TGF-b1
under high glucose conditions were detected to further confirm
whether EMT could be induced by high glucose. The results
showed that high glucose could induce EMT in human renal
epithelial cells, which became more elongated and less adhered
and lost their apical-to-basal polarity. During this process, cells lost
E-cadherin and CK, showed increased de novo expression of a-
SMA and vimentin and synthesized extracellular matrix mole-
cules, such as fibronectin, which are features that are consistent
with a more fibroblast-like phentoype. The activation of
myofibroblasts plays a critical role in the processes of cell
adhesion, actin re-organization and enhanced cellular progression
of chronic renal disease. The role of p38 MAPK in tubular EMT is
further supported by the p38 siRNA findings. In this study, p38
siRNA was shown to reverse the loss in E-cadherin and CK,
suppress the expression of a-SMA and vimentin and inhibit
fibronectin synthesis: these effects limited the development of the
high glucose-induced epithelial mesenchymal transition. More
Figure 6. Effect of knockdown of p38MAPK by p38 MAPK siRNA on p38 MAPK expression by Western blot and RT-PCR analysis.
(A)P38 MAPK expression were determined by RT-PCR of the HK-2 cells cultured for 72 h in 5.5 mM glucose (lane 1), 5.5 mM glucose+Cont siRNA (lane
2), 5.5 mM glucose+p38 siRNA (lane 3). (B)P38 MAPK expression were determined by Western blot of the HK-2 cells cultured for 72 h in 5.5 mM
glucose (lane 1), 5.5 mM glucose+Cont siRNA (lane 2), 5.5 mM glucose+p38 siRNA (lane 3).Values represent the mean 6 SD,
aP,0.05 vs. 5.5 mM
glucose.
doi:10.1371/journal.pone.0022806.g006
Figure 7. The expression of p38 MAPK and phosphorylated
P38 MAPK by Western blot analysis. p38 MAPK and phosphory-
lated p38 MAPK were measured by Western blot of the HK-2 cells
cultured in 5.5 mM glucose (lane 1), 30 mM glucose (lane 2), 30 mM
glucose+Cont siRNA(lane 3), 30 mM glucose+p38 siRNA for 24 h(lane
4), 30 mM glucose+p38 siRNA for 48 h(lane 5). Values represent the
mean 6 SD,
aP,0.05 vs. 5.5 mM glucose,
bP,0.05 vs. 30 mM glucose.
doi:10.1371/journal.pone.0022806.g007
p38 MAPK in Epithelial-Mesenchymal Transition
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22806intrestingly, increased apoptosis were also observed in cells in high
glucose conditions for 48 h (Figure S1). The underlying mecha-
nism of this high glucose-induced apoptosis is to be further
elucidated.
Because MAPKs have been shown to play an important role in
the up-regulation of AP-1 activation in various types of cultured
cells via multiple mechanisms, we attempted to examine the
possible involvement of p38 MAPK, which is the major upstream
kinase, in the activation of AP-1 in HK-2 cells. AP-1 activity is
rapidly induced by a broad range of stimuli, including growth
factors, cytokines, stress signals, and infections, as well as
oncogenic stimuli; therefore, AP-1 mediates many physiological
processes, such as proliferation, survival, differentiation, apoptosis,
and transformation [48]. The role of the AP-1 transcriptional
complex in EMT has received little attention in the past and to our
knowledge, data on the function of AP-1 in high glucose-induced
EMT are lacking. The results of the present study provide strong
evidence to support the role of AP-1 in high glucose-induced
EMT. AP-1 has been shown to be a potential downstream
therapeutic target in p38 MAPK-mediated diseases [49]. The
findings in our study included the induction of AP-1 under high
glucose conditions and its partial abrogation mediated by p38
siRNA. The levels of AP-1 binding activity were increased under
high glucose conditions but were decreased after transfection with
p38 siRNA. To further study AP-1 transactivation in high glucose-
induced EMT, experiments demonstrated that [6]-Gingerol,
Figure 8. Expression of E-cadherin, CK, a-SMA, vimentin in HK-2 cells by Western blot. (A)a-SMA, (B)E-caderin, (C)CK, (D)vimentin were
measured by Western blot of the HK-2 cells cultured in 5.5 mM glucose (lane 1), 5.5 mM glucose with p38 siRNA (lane 2), 5.5 mM glucose with AP-1
inhibitor (lane 3), 5.5 mM glucose+TGF-b1 (10 ng/ml) (lane 4), 5.5 mM glucose+TGF-b1(10 ng/ml) with p38 siRNA (lane 5), 5.5 mM glucose+TGF-
b1(10 ng/ml) with the AP-1 inhibitor (lane 6).
aP,0.05 vs. 5.5 mM glucose,
bP,0.05 vs. 5.5 mM glucose+TGF-b1.
doi:10.1371/journal.pone.0022806.g008
Figure 9. Fibronectin synthesis in HK-2 cells by ELISA.
Fibronectin was measured by ELISA of the HK-2 cells in 5.5 mM glucose
(lane 1), 30 mM glucose(lane 2), 30 mM glucose+Cont siRNA(lane 3),
30 mM glucose+p38 siRNA for 24 h(lane 4), 30 mM glucose+p38 siRNA
for 48 h(lane 5) and 30 mM glucose+AP-1 inhibitor(lane 6). Values
represent the mean 6 SD,
aP,0.05 vs. 5.5 mM glucose,
bP,0.05 vs.
30 mM glucose.
doi:10.1371/journal.pone.0022806.g009
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induced activation of AP-1. With high glucose treatment, HK-2
cells underwent striking morphological alterations, including
membrane ruffling, numerous pseudopodial protrusions, increased
cell motility and anchorage-independent (invasive) growth. These
changes were inhibited by pre-treatment with [6]-Gingerol.
The Snail family members have been shown to be involved in
the regulation of EMT during embryonic development and tumor
progression [50]. Snail possesses DNA binding capacity and
recognizes the E-box elements in the promoter region of its target
genes, which include E-cadherin. Binding of Snail to its cognate E-
box often leads to the suppression of gene transcription [51,52].
Earlier studies showed that induction of Snail, which commonly
occurs in malignant carcinomas, suppresses epithelial E-cadherin
expression [53,54]. In this study, Snail expression was promoted in
HK-2 cells under high glucose conditions, but knockdown of p38
MAPK and pretreatment with [6]-Gingerol reversed the increased
Snail expression, which suggests that Snail expression in vitro is
dependent on the p38/AP-1 signaling pathway. The expression of
Snail suppressed the expression of E-cadherin protein. Although
the underlying mechanism of Snail inhibition remains to be
elucidated, the finding that p38/AP-1 is able to target Snail, which
is a key EMT-regulatory gene, highlights a fundamental step in the
p38/AP-1 signaling pathway in high glucose-induced EMT, which
may prove its role in TIF.
This study provides a novel insight into the role of the p38/AP-
1 signaling pathway, which was shown to be a crucial step in high
glucose-induced EMT in HK-2 cells. The results indicate that the
striking changes in TECs were induced by high glucose; these
changes include the following: the activation of phosphorylated
Figure 10. Activity of AP-1 in HK-2 cells by EMSA. (A)AP-1 activity was analyzed by EMSA of the HK-2 cells cultured in 5.5 mM glucose (lane 1),
30 mM glucose(lane 2), 30 mM glucose+Cont siRNA(lane 3), 30 mM glucose+p38 siRNA for 24 h (lane 4), 30 mM glucose+p38 siRNA for 48 h(lane
5).(B) AP-1 activity was analyzed by EMSA of the HK-2 cells cultured in 5.5 mM glucose(lane 1), 30 mM glucose (lane 2) and 30 mM glucose+AP-1
inhibitor(lane 3). Values represent the mean 6 SD,
aP,0.05 vs. 5.5 mM glucose,
bP,0.05 vs. 30 mM glucose.
doi:10.1371/journal.pone.0022806.g010
Figure 11. Expression and phosphorylation of p38 MAPK in
HK-2 cells by Western blot. Expression and phosphorylation of p38
MAPK under 5.5 mM glucose (lane 1), 30 mM glucose(lane 2) and
30 mM glucose+AP-1 inhibitor were determined by.
aP,0.05 vs.
5.5 mM glucose.
doi:10.1371/journal.pone.0022806.g011
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epithelial markers, E-cadherin and CK; de novo expression of
vimentin and a-SMA; and an increase in fibronectin levels. The
siRNA-mediated down-regulation of p38 expression prevented
AP-1 activation and the high glucose-induced EMT. In addition,
the suppression of the AP-1 transcriptional complex blocked the
high glucose-induced EMT. The inhibition of the p38/AP-1
signaling pathway limited the development of the EMT in vitro
and suppressed the expression of Snail, which is a key EMT-
regulatory gene. Taken together, this study suggests the p38
MAPK pathway may play an important role in high glucose-
induced EMT through the activation of AP-1 in tubular epithelial
cells.
Materials and Methods
Antibodies and chemical inhibitors
Anti-phospho-p38 antibodies and anti-p38 antibodies were
purchased from Cell Signaling Technology (USA). Anti-E-
cadherin, anti-a-SMA, anti-vimentin, anti-CK and anti-TGF-b1
antibodies were purchased from Santa Cruz Biotechnology, Inc.
(USA), and [6]-Gingerol was purchased from Wako Ltd. (Japan).
Figure 12. Expression of E-cadherin, CK, a-SMA, vimentin in HK-2 cells by Western blot and RT-PCR analysis. (A–B)a-SMA(A) and E-
cadherin(B) were detected by Western blot of the HK-2 cells incubated in 5.5 mM glucose (lane 1), 30 mM glucose(lane 2), 30 mM glucose+AP-1
inhibitor(lane 3).(C–D)mRNA of CK(C) and vimentin(D) was measured by RT-PCR of the HK-2 cells incubated in 5.5 mM glucose (lane 1), 30 mM
glucose(lane 2), 30 mM glucose+AP-1 inhibitor(lane 3). Values represent the mean 6 SD.
aP,0.05 vs. 5.5 mM glucose,
bP,0.05 vs. 30 mM glucose.
doi:10.1371/journal.pone.0022806.g012
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Experiments were performed with HK-2 cells (American Type
Culture Collection number CRL-2190), which are human
proximal tubular epithelial cells immortalized by transduction
with human papillomavirus type 16 E6/E7 genes. Cells were
cultured in Dulbecco’s modified Eagle’s medium (low glucose)
(Gibco, UK) that was supplemented with 10% fetal calf serum
(Sigma, USA). The cells were seeded at 1.5610
6 cells/10 cm
diameter dishes for 3–4 days at 37uC in a humidified atmosphere
containing 5% CO2.
Transfection of siRNA
To silence the p38 MAPK gene expression, siRNA oligonucle-
otides with the following sequences were designed: p38 siRNA,
59-GAAGCTCTCCAGACCATTT-39 and negative Cont-siRNA,
59 -GACTTCATAAGGCGCATGC-39. The HK-2 cells were
cultured for 24 h before the transfection. After a 24-h or 48-h
incubation with p38 siRNA or a 24-h incubation with Cont-
siRNA, the cells were cultured with high glucose (30 mM glucose)
for an additional 48 h. Cells that were not transfected and were
exposed to normal glucose (5.5 mM glucose) or high glucose
(30 mM glucose) for 48 h were considered to be the controls.
Transfection was processed in 24-well plates with 40 nM siRNAs
using Lipofectamine2000 (Invitrogen). p38 MAPK knockdown
was confirmed by Western blot analysis and reverse transcription-
PCR (RT-PCR).
SDS-PAGE and Western blot analysis
Cells were washed twice with PBS and lysed with 2X SDS-
PAGE sample buffer. Next, 50 mg of total protein was separated
by 10% SDS-PAGE and transferred to nitrocellulose membranes;
the membranes were then blocked with 1% polyvinylalcohol in
PBS containing 0.2% Tween 20 for 10 min and incubated at 4uC
overnight with primary antibodies (diluted to various concentra-
tions in blocking buffer (5% or 1% skim milk in PBS-Tween (0.2%
Tween 20)) against the following target proteins: p38, phospho-
p38 (1:1000), E-cadherin (1:200), a-SMA (1:200), CK (1:200),
Vimentin (1:600), TGF-b1 (1:500) and b-actin (1:2000). The
membranes were then washed three times with PBS-Tween for
10 min and incubated with species-specific peroxidase-conjugated
secondary antibodies (Santa Cruz, CA) diluted in blocking buffer
(5% skim milk in PBS-Tween) for 2 h at room temperature.
Specific bands were detected using the ECL system (Amersham)
and the Bio-Rad electrophoresis image analyzer (Bio-Rad, Hemel
Hampstead, UK).
RNA extraction and reverse transcription
Total RNA was extracted from the HK-2 cells using the
Tripure reagent (Roche, Germany) according to the manufactur-
er’s instructions. RNA samples were qualified by the measurement
of the optic absorbance at 260 and 280 nm with a resultant A260/
A280 ratio that ranged from 1.8 to 2.0, which indicated a high
purity of the extracted RNA. The concentration of total RNA was
calculated according to A260. Aliquots of total RNA (1.0 mg each)
from each sample were reverse transcribed into cDNA according
to the instructions of the First Strand cDNA Synthesis Kit (Takara,
China).
Reverse Transcriptase-PCR
Semiquantitative reverse transcriptase-PCR (RT-PCR) was
used to determine the steady-state mRNA levels of Snail, CK
and vimentin. Briefly, after reverse transcription of renal total
RNA, cDNA was used as a template for the PCR reactions using
gene-specific primer pairs. Generally, 30 to 35 cycles for
amplification in the linear range were used. Quantification of
PCR products was performed using densitometry, and the relative
Figure 13. The expression of Snail mRNA in HK-2 cells by RT-PCR. (A)The levels of Snail mRNA were detected by RT-PCR of the HK-2 cells
cultured in 5.5 mM glucose (lane 1), 30 mM glucose (lane 2), 30 mM glucose+Cont siRNA (lane 3), 30 mM glucose+p38 siRNA for 24 h (lane 4), 30 mM
glucose DMEM+p38 siRNA for 48 h(lane 5).(B)The levels of the Snail mRNA were detected by RT-PCR of the HK-2 cells incubated in 5.5 mM glucose
(lane 1), 30 mM glucose (lane 2), and 30 mM glucose+AP-1 inhibitor (lane 3). Values represent the mean 6 SD, aP,0.05 vs. 5.5 mM glucose, bP,0.05
vs. 30 mM glucose.
doi:10.1371/journal.pone.0022806.g013
p38 MAPK in Epithelial-Mesenchymal Transition
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22806mRNA levels were calculated and compared after normalization
to beta-actin. The primers for the RT-PCR reaction were
purchased from Sangon Biotech (China). The sequences were as
follows: Snail (human), sense 59-CATTC CACGCCCAGC-
TACCC-39 and antisense 59-CGCCCAGGCTC ACA-
TATTCC-39; CK mRNA, sense 59-CCCAGAGCCTTGAGA-
TAGAA C-39 and antisense 59-CACGACCTTGCCATCCAC-
39; vimentin mRNA, sense 59-CGCTTCGCCAACTACAT C-39
and antisense 59-GGTCAGGCTT GGAAACATC-39; and beta-
actin, sense 59-CACCAACTGGGACG ACAT-39 and antisense
59-AC AGCCTGGATAGCAACG-39.
Transmission electron microscopy
For transmission electron microscope analysis, HK-2 cells were
harvested, pre-fixed with 2% glutaraldehyde for 2 h at 4uC,
washed twice with PBS, and then post-fixed with 1% osmic acid
for 2 hours at 4uC. After an additional two washes in PBS, the
samples were dehydrated with an ethanol gradient, washed twice
with propylene oxide, soaked in ethoxyline resin overnight, and
mounted at 60uC for 48 hours. Thin sections were cut with an
ultramicrotome and then viewed under a transmission electron
microscope (Hitachi, Japan).
ELISA (enzyme-linked immunosorbent assay)
Fibronectin release was determined using a Fibronectin ELISA
kit (Jingmei BioTech, China). After exposure to the defined
experimental conditions, culture supernatants were harvested.
Different concentrations of supernatants were added to 96-well
plates for 2 h at 37uC, followed by three washes with PBST buffer.
Next, 100 ml of peroxidase-conjugated IgG (diluted with PBS to a
concentration of 1:5000) was added to each well, and the plates
were incubated at 25uC for 2 h. After the plates were washed three
times with PBST, 100 ml of substrate solution (3, 39,5 ,5 9-
tetramethylbenzidine, TMB) was added to each well using a
multichannel pipet. The reaction was stopped by adding 50 mlo f
2.0 M sulfuric acid to each well. After sufficient color
development, absorbance values were immediately determined
with an ELISA reader at a wavelength of 450 nm.
Immunocytochemistry
Cells under different conditions were plated onto different six-
well plates at a density of 1610
5 cells/well; each well contained a
polylysine-coated slide. Cells were fixed in 4% PFA for 15 min at
4uC and individually stained with monoclonal antibodies to E-
cadherin, a-SMA, vimentin and CK using immunocytochemistry
according to the instructions in the immunocytochemical detection
kit (Zhongshan Goldbridge Biotech, China). Briefly, HK-2 cells
were rinsed in phosphate-buffered saline, fixed in 2% paraformal-
dehyde, preincubatedwith 10%fetalcalf serum to blocknonspecific
binding, and then incubated with antibodies for 60 min. After
washing with phosphate-buffered saline, endogenous peroxidase
was inactivated by incubation with 0.3% H2O2 in methanol for
15 min; this wasfollowed byincubationwithperoxidase-conjugated
IgG and peroxidase-conjugated anti-peroxidase complexes and
color development with diaminobenzidine to produce a brown
color. All procedures were performed at room temperature. Data
from five experiments were expressed as the mean percentage.
EMSA
The nuclear extracts were prepared from the cells under the
different conditions. The EMSA was performed using the
LightShift chemiluminescent EMSA kit (Pierce, Rockford, USA)
according to the manufacturer’s instructions. Briefly, the biotin-
labeled probes were incubated with the nuclear extracts for
30 min at 37uC, and the reaction samples were electrophoresed on
a 4% non-denaturing acrylamide gel in a 0.5X Tris-borate-EDTA
buffer. After transfer to nylon membranes, the biotin-labeled
probes were detected. The following AP-1 probe was used for the
EMSA: AP-1 response element (AP1, 59CGC TTG ATG AGT
CAG CCG GAA39)
Data analysis
All experiments were repeated at least three times. Values were
reported as mean 6 SD. Data were analyzed using SPSS 13.0
software. Statistical significance was assessed using ANOVA and
LSD-t test, and P values of less than 0.05 were considered to be
statistically significant.
Supporting Information
Figure S1 HK-2 cells apoptosis were measured by flow
cytometry. (A) shows the rate of apoptosis in HK-2 cells under
5.5 mM glucose conditions for 48 h (lane 1), (B) shows the rate of
apoptosis in HK-2 cells under 30 mM glucose conditions for 48 h
(lane2).
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